Hormonal Contraceptive Use Is Associated with Higher Total but Unaltered Free 25-Hydroxyvitamin D Serum Concentrations

Journal of Clinical Endocrinology and Metabolism

Volumn 103, Issue 6, 2018, Pages 2385-2391

  Pilz, Stefan ^a   Obeid, Rima ^b   Schwetz, Verena ^a   Trummer, Christian ^a   Pandis, Marlene ^a   Lerchbaum, Elisabeth ^a   Pieber, Thomas R ^a   Obermayer Pietsch, Barbara ^a   Wilhelm, Manfred ^c   Hahn, Andreas ^d   Schön, Christiane ^e  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b SAARLAND UNIVERSITY   (Germany)

^c ULM UNIVERSITY OF APPLIED SCIENCES   (Germany)

^d LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^e BIOTESYS GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; CONTRACEPTIVE AGENT; ELEVIT; FEMIBION; TRACE ELEMENT; 25-HYDROXYVITAMIN D; ORAL CONTRACEPTIVE AGENT; VITAMIN D;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GERMANY; HORMONAL CONTRACEPTION; HUMAN; MAJOR CLINICAL STUDY; POST HOC ANALYSIS; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; DIETARY SUPPLEMENT; DOUBLE BLIND PROCEDURE; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; CHOLECALCIFEROL; CONTRACEPTIVES, ORAL, HORMONAL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; VITAMIN D; YOUNG ADULT;

EID: 85048677813     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2018-00336     Document Type: Article

References (31)

1. Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, Moreno L, Damsgaard CT, Michaelsen KF, Mølgaard C, Jorde R, Grimnes G, Moschonis G, Mavrogianni C, Manios Y, Thamm M, Mensink GB, Rabenberg M, Busch MA, Cox L, Meadows S, Goldberg G, Prentice A, Dekker JM, Nijpels G, Pilz S, Swart KM, van Schoor NM, Lips P, Eiriksdottir G, Gudnason V, Cotch MF, Koskinen S, Lamberg-Allardt C, Durazo- Arvizu RA, Sempos CT, Kiely M. Vitamin D deficiency in Europe: pandemic? Am J Clin Nutr. 2016;103(4):1033-1044.
2. Autier P, Mullie P, Macacu A, Dragomir M, Boniol M, Coppens K, Pizot C, Boniol M. Effect of vitamin D supplementation on nonskeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol. 2017;5(12): 986-1004.
3. Rejnmark L, Bislev LS, Cashman KD, Eiríksdottir G, Gaksch M, Grübler M, Grimnes G, Gudnason V, Lips P, Pilz S, van Schoor NM, Kiely M, Jorde R. Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data. PLoS One. 2017;12(7): e0180512.
4. Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, Mathiesen EB, Njølstad I, Løchen ML, Marz W, Kleber ME, Tomaschitz A, Grübler M, Eiriksdottir G, Gudmundsson EF, Harris TB, Cotch MF, Aspelund T, Gudnason V, Rutters F, Beulens JW, van 't Riet E, Nijpels G, Dekker JM, Grove-Laugesen D, Rejnmark L, Busch MA, Mensink GB, Scheidt- Nave C, Thamm M, Swart KM, Brouwer IA, Lips P, van Schoor NM, Sempos CT, Durazo-Arvizu RA, Škrabáková Z, Dowling KG, Cashman KD, Kiely M, Pilz S. Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium. PLoS One. 2017;12(2):e0170791.
5. Pilz S, Verheyen N, Grubler MR, Tomaschitz A, Marz W. Vitamin D and cardiovascular disease prevention. Nat Rev Cardiol. 2016; 13(7):404-417.
6. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-58.
7. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM; Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-1930.
8. Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M. Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol. 2014;144(Pt A):132-137.
9. Xie Z, Santora AC, Shapses SA, Wang X. Vitamin D binding protein and vitamin D levels. Int J Endocrinol. 2014;2014:638263.
10. Bikle DD, Malmstroem S, Schwartz J. Current controversies: are free vitamin metabolite levels a more accurate assessment of vitamin D status than total levels? Endocrinol Metab Clin North Am. 2017;46(4):901-918.
11. Harmon QE, Umbach DM, Baird DD. Use of estrogen-containing contraception is associated with increased concentrations of 25- hydroxy vitamin D. J Clin Endocrinol Metab. 2016;101(9): 3370-3377.
12. Nelson ML, Blum JM, Hollis BW, Rosen C, Sullivan SS. Supplements of 20 microg/d cholecalciferol optimized serum 25- hydroxyvitamin D concentrations in 80% of premenopausal women in winter. J Nutr. 2009;139(3):540-546.
13. Møller UK, Streym S, Jensen LT, Mosekilde L, Schoenmakers I, Nigdikar S, Rejnmark L. Increased plasma concentrations of vitaminDmetabolites and vitamin D binding protein in women using hormonal contraceptives: a cross-sectional study. Nutrients. 2013; 5(9):3470-3480.
14. Oleröd G, Hultén LM, Hammarsten O, Klingberg E. The variation in free 25-hydroxy vitamin D and vitamin D-binding protein with season and vitamin D status. Endocr Connect. 2017;6(2):111-120.
15. Pilz S, Hahn A, Schön C, Wilhelm M, Obeid R. Effect of two different multimicronutrient supplements on vitamin D status in women of childbearing age: a randomized trial. Nutrients. 2017; 9(1):30.
16. Harris SS, Dawson-Hughes B. The association of oral contraceptive use with plasma 25-hydroxyvitamin D levels. J Am Coll Nutr. 1998;17(3):282-284.
17. Rabenberg M, Scheidt-Nave C, Busch MA, Rieckmann N, Hintzpeter B, Mensink GB. Vitamin D status among adults in Germany-results from the German Health Interview and Examination Survey for Adults (DEGS1). BMC Public Health. 2015; 15(1):641.
18. Bansal N, Katz R, de Boer IH, Kestenbaum B, Siscovick DS, Hoofnagle AN, Tracy R, Laughlin GA, Criqui MH, Budoff MJ, Li D, Ix JH. Influence of estrogen therapy on calcium, phosphorus, and other regulatory hormones in postmenopausal women: the MESA study. J Clin Endocrinol Metab. 2013;98(12):4890-4898.
19. Johnson S, Pion C, Jennings V. Current methods and attitudes of women towards contraception in Europe and America. Reprod Health. 2013;10(1):7.
20. Obeid R, Schön C, Wilhelm M, Pietrzik K, Pilz S. The effectiveness of daily supplementation with 400 or 800 mg/day folate in reaching protective red blood folate concentrations in nonpregnant women: a randomized trial [published online ahead of print April 26, 2017]. Eur J Nutr.
21. Obeid R, Schön C, Wilhelm M, Shrestha RP, Pilz S, Pietrzik K. Response of red blood cell folate to supplementation in nonpregnant women is predictable: a proposal for personalized supplementation. Mol Nutr Food Res. 2018;62(4):1700537.
22. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, Elbourne D, Egger M, Altman DG. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340(mar23 1):c869.
23. Heureux N, Lindhout E, Swinkels L. A direct assay for measuring free 25-hydroxyvitamin D. J AOAC Int. 2017;100(5):1318-1322.
24. Nielson CM, Jones KS, Bouillon R, Chun RF, Jacobs J, Wang Y, Hewison M, Adams JS, Swanson CM, Lee CG, Vanderschueren D, Pauwels S, Prentice A, Smith RD, Shi T, Gao Y, Zmuda JM, Lapidus J, Cauley JA, Schoenmakers I, Orwoll ES; Osteoporotic Fractures in Men (MrOS) Research Group. Role of assay type in determining free 25-hydroxyvitamin D levels in diverse populations. N Engl J Med. 2016;374(17):1695-1696.
25. Nielson CM, Jones KS, Chun RF, Jacobs JM, Wang Y, Hewison M, Adams JS, Swanson CM, Lee CG, Vanderschueren D, Pauwels S, Prentice A, Smith RD, Shi T, Gao Y, Schepmoes AA, Zmuda JM, Lapidus J, Cauley JA, Bouillon R, Schoenmakers I, Orwoll ES; Osteoporotic Fractures in Men (MrOS) Research Group. Free 25-hydroxyvitamin D: impact of vitamin D binding protein assays on racial-genotypic associations. J Clin Endocrinol Metab. 2016;101(5):2226-2234.
26. Sollid ST, Hutchinson MY, Berg V, Fuskevag OM, Figenschau Y, Thorsby PM, Jorde R. Effects of vitamin D binding protein phenotypes and vitamin D supplementation on serum total 25(OH)D and directly measured free 25(OH)D. Eur J Endocrinol. 2016; 174(4):445-452.
27. Cross HS, Kállay E, Khorchide M, Lechner D. Regulation of extrarenal synthesis of 1, 25-dihydroxyvitamin D3-relevance for colonic cancer prevention and therapy. Mol Aspects Med. 2003; 24(6):459-465.
28. Saarem K, Pedersen JI. Sex differences in the hydroxylation of cholecalciferol and of 5 beta-cholestane-3 alpha, 7 alpha, 12 alphatriol in rat liver. Biochem J. 1987;247(1):73-78.
29. Lee CC, Young KA, Norris JM, Rotter JI, Liu Y, Lorenzo C, Wagenknecht LE, Cole DE, Haffner SM, Chen YI, Hanley AJ. Association of directly measured plasma free 25(OH)D with insulin sensitivity and secretion: the IRAS Family Study. J Clin Endocrinol Metab. 2017;102(8):2781-2788.
30. Chun RF, Hernandez I, Pereira R, Swinkles L, Huijs T, Zhou R, Liu NQ, Shieh A, Guemes M, Mallya SM, Adams JS, Hewison M. Differential responses to vitamin D2 and vitamin D3 are associated with variations in free 25-hydroxyvitamin D. Endocrinology. 2016;157(9):3420-3430.
31. Bouillon R. Free or total 25OHD as marker for vitamin D status? J Bone Miner Res. 2016;31(6):1124-1127.